Issues in Pharmaceuticals by Disease, Disorder, or Organ System: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Additional Research. The editors have built Issues in Pharmaceuticals by Disease, Disorder, or Organ System: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Additional Research in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Pharmaceuticals by Disease, Disorder, or Organ System: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

Issues in Pharmaceuticals by Disease, Disorder, or Organ System: 2012 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Ocular Pharmacology and Therapeutics in a compact format. The editors have built Issues in Pharmaceuticals by Disease, Disorder, or Organ System: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Ocular Pharmacology and Therapeutics in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Pharmaceuticals by Disease, Disorder, or Organ System: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

Issues in Birth Defects and Congenital and Genetic Diseases and Disorders: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Teratology. The editors have built Issues in Birth Defects and Congenital and Genetic Diseases and Disorders: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Teratology in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Birth Defects and Congenital and Genetic Diseases and Disorders: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

This issue of Medical Clinics covers the current best practices surrounding the perioperative management of patients with chronic diseases. Guest edited by Jeffrey Kirsch and Ansgar Brambrink, the topics covered will include patients with pacemakers, patients with endocrine disease, immunocompromised patients, patients with heart disease, patients with renal disease, and more.

This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.

Dr. Kliegman and Dr. Bordini have written a primer on Undiagnosed and Rare Diseases in Children. Leading experts have presented the current knowledge in the following areas: How Doctor’s Think: Common Diagnostic Errors in Clinical Judgment; Team-Based Approach to Undiagnosed and Rare Diseases; Ending a Diagnostic Odyssey: Family Education Counselling and Their Response to Eventual Diagnosis; Eczema and Urticaria as Manifestations of Undiagnosed and Rare Diseases; Usual and Unusual Manifestations of Familial Hemophagocytic and Langerhans Cell Histiocytosis Syndromes; When Autistic Behavior Suggests a Disease Other than Classic Autism; Non-classic Inflammatory Bowel Disease in Young Infants; IPEX and Other Disorders; Usual and Unusual Presentation of Mitochondrial Disorders; When to Suspect Auto-inflammatory/Recurrent Fever Syndromes; Primary and Secondary Causes of Autonomic Dysfunction; Usual and Unusual Manifestations of Systemic and CNS Vasculitis; Fever of Unknown Origin; Differentiating Familial Neuropathies from Guillain-Barre Syndrome; and Munchausen by Proxy: A Factitious Undiagnosed Disease. Readers will come away with cutting-edge information to use immediately in their clinical management of patients.

This updated and refined new edition is the only book to provide a comprehensive approach to the intensive care of neurologically injured patients from the emergency room and ICU through the operating room and post-surgical period. It reviews neuroanatomy, neuroradiology, and neurophysiology, examines the neurological problems most frequently seen in intensive care, and describes the various types of neurosurgery. General issues are discussed, such as cardiac care, fluids and electrolytes, nutrition, and monitoring as well as more specific conditions and complications including elevated intracranial pressure, seizures, and altered mental states.

Vasculitis is a term for a group of rare diseases that have in common inflammation of blood vessels and there are many types of vasculitis, and they may vary greatly in symptoms, severity and duration. Vasculitis can range from mild to life-threatening and early detection and treatment of severe vasculitis can prevent permanent damage.

This issue of Radiologic Clinics of North America focuses on Imaging of Selected Multi-System Disorders. Articles will include: von Hippel-Lindau syndrome: Review of Genetics and Imaging; Cross-sectional Imaging Review of Tuberous Sclerosis; Multiple Endocrine Neoplasia Syndromes: A Comprehensive Imaging Review; Imaging Manifestations of Thoracic Tuberculosis; Imaging Spectrum of Extra-Thoracic Tuberculosis; MDCT and MRI Findings of Mycotic Infections; Imaging of Sarcoidosis: A Contemporary Review; Imaging of Inflammatory Myofibroblastic Tumor; Recent Advances in Imaging of IgG4-related Disease; Systemic Vasculopathy Syndromes: Overview of Imaging & Management; Taxonomy and Imaging Manifestations of Systemic Amyloidosis; State of the Art Imaging & Staging of Multiple Myeloma & Plasmacytoma; Solitary Fibrous Tumor: 2016 Imaging Update; and more!